Vuélvete ilimitado con Magzter GOLD

Vuélvete ilimitado con Magzter GOLD

Obtenga acceso ilimitado a más de 9000 revistas, periódicos e historias Premium por solo

$149.99
 
$74.99/Año
The Perfect Holiday Gift Gift Now

"The ecosystem of Gujarat is ready to promote deep tech areas of biotech product development"

Bio Spectrum

|

BioSpectrum Indian Feb 2025

ujarat has more than 200 biotechnology Gamers and a thriving startup ecosystem that includes prominent R&D and educational institutes. Gujarat's biotech sector generates more than Rs 12000 crore revenue and serves as an established biomanufacturing hub. Playing a key role in this direction is the Gujarat State Biotechnology Mission GSBTM) which has completed 20 years. The Government of Gujarat GoG) had established GSBTM in April 2004 under the Department of Science and Technology to facilitate the development of the biotech sector. In conversation with BioSpectrum, Manish Gurwani, Mission Director, Gujarat State Biotechnology Mission elaborates on how GSBTM’s latest biotechnology policy is transforming the sector in Gujarat. Edited excerpts:

- Ankit Kankar

"The ecosystem of Gujarat is ready to promote deep tech areas of biotech product development"

How does the GSBTM plan to leverage infrastructure and incentives under the current policy to position the state as a globally competitive biotechnology hub?

Known for its entrepreneurship spirit, Gujarat has continued to be one of the preferred investment destinations for Ease of Doing Business (EoDB), Good Governance Index (GGI), Energy & Climate Index, Startup & LEADS ranking. The state contributes 40 per cent to India’s total cargo throughput with ~8.2 per cent in India’s GDP (as on FY2022-23 on current price). The state accounts for $12 billion (2023) with 8 per cent share of Bioeconomy, way above ~4 per cent state-wise average contribution of Bio-economy, amongst top 5 states of India in terms of Bio-economy contributors. This is the result of its top-class trunk and core infrastructure coupled with a safe and sound social environment in attracting top entrepreneurs from various parts of the country and abroad.

Gujarat showed great foresight, by setting up a dedicated mission office two decades ago, the Gujarat State Biotechnology Mission (GSBTM) followed by eco-system strengthening initiatives like Gujarat Biotechnology Research Centre (GBRC), Gujarat Biotechnology University (GBU) – Asia’s first ever dedicated biotechnology university and one of the top 5 public incubators Savli Technology and Business Incubator (STBI) with dedicated biotechnology parks for greenfield and brownfield spaces. These initiatives indicate Gujarat’s readiness to attract top biotech players in one of the thriving biotech ecosystems. GSBTM not only operates different schemes for facilitation of biotechnology, but is also the single window clearance office for all purposes, bringing in ease of doing business.

MÁS HISTORIAS DE Bio Spectrum

Bio Spectrum

Bio Spectrum

India's Strategic Shift Towards High-Quality, Low-Cost MedTech

India's healthcare infrastructure continues to face significant strain from the rising prevalence of non-communicable diseases (NCDs), contributing around 66 per cent of the mortalities in the country, underscoring the need for scalable continuous monitoring, early diagnosis, and therapeutic devices. Yet, advanced imaging systems, analysers, surgical tools, or robotic devices remain very expensive due to import reliance, high logistics costs, and maintenance/ service contracts. Segments showing strongest traction today are diagnostics (point-of-care devices, rapid tests, compact imaging devices), remote monitoring/wearable devices, and therapeutic devices such as surgical robotic systems, renal care systems, and wound care devices.

time to read

4 mins

December 2025

Bio Spectrum

Bio Spectrum

How India's Diabetes Crisis is Driving Med Devices Market

A growing diabetic population in India is a blessing for the care devices market. Both Indian and global diabetes care devices have taken this growing demand for various devices, kits as an opportunity to expand their market share. But the scope in rural areas seems a bit challenging for various companies due to less awareness about the disease, affordability etc. Let's look at this growing diabetes care devices market.

time to read

9 mins

December 2025

Bio Spectrum

Thermo Fisher Scientific invests Rs 160 Cr+ to expand Bengaluru R&D facility

Thermo Fisher Scientific's expanded Research and Development (R&D) Centre of Excellence was inaugurated in Bengaluru by Sanjeev Kumar Gupta, CEO, Karnataka Digital Economy Mission (KDEM).

time to read

1 min

December 2025

Bio Spectrum

Bio Spectrum

Motorica strengthens India presence with appointment of Kavinder Beniwal as COO

Motorica, a Delhi-based medtech company specialising in assistive technologies and medical cybernetics, has announced the appointment of Kavinder Beniwal as Chief Operational Officer (COO) of Motorica India.

time to read

1 min

December 2025

Bio Spectrum

Bio Spectrum

Cabinet approves major expansion of PG and UG medical education capacity

Union Cabinet chaired by the Prime Minister Narendra Modi has approved the Phase-Ill of the Centrally Sponsored Scheme (CSS) for strengthening and upgradation of existing State Government/ Central Government Medical Colleges/Standalone PG Institutes/ Government Hospitals for increasing 5,000 PG seats and extension of the CSS for upgradation of existing government medical colleges for increasing 5,023 MBBS seats with an enhanced cost ceiling of Rs 1.5 crore per seat.

time to read

1 min

December 2025

Bio Spectrum

Bio Spectrum

Dr Sharvil Patel steps in as Indian Pharmaceutical Alliance President

The Indian Pharmaceutical Alliance (IPA) has announced a leadership transition, with Dr Sharvil Patel, Managing Director of Zydus Lifesciences and former Vice President of IPA, assuming the role of President.

time to read

1 min

December 2025

Bio Spectrum

Bio Spectrum

PAG-led Sekhmet Pharmaventures announces appointment of Mukesh Agarwal as CFO

Hyderabad-based Sekhmet Pharmaventures, a fast-emerging global API/CDMO player led by leading Asia-focused investment firm PAG, has announced the appointment of Mukesh Agarwal as its new Chief Financial Officer (CFO).

time to read

1 min

December 2025

Bio Spectrum

Monash University Malaysia and Tata Chemicals forge healthcare researchfocused partnership

The importance of gastrointestinal health is a key focus for researchers and innovators, as highlighted by the partnership between Monash University Malaysia and Tata Chemicals Limited.

time to read

1 min

December 2025

Bio Spectrum

Bio Spectrum

"India has the talent and ambition to lead globally in advanced therapies, biologics, and oncology"

Thermo Fisher Scientific has recently announced plans to make significant investments in India's biopharma infrastructure, with new facilities that will enhance the biopharma manufacturing capabilities. Central to this expansion strategy are two major facilities in Genome Valley, Hyderabad, i.e. Bioprocess Design Center (BDC), and Customer Experience Center (CEC). In addition, the company has invested more than Rs 160 crore this year to expand its R&D facility in Bengaluru. For further understanding on these new developments, BioSpectrum spoke in detail to Srinath Venkatesh, Managing Director, India & South Asia, Thermo Fisher Scientific. Edited excerpts;

time to read

4 mins

December 2025

Bio Spectrum

Bio Spectrum

"AI is a transformative enabler that's reshaping how science is conducted in labs"

2025 witnessed multiple new initiatives taken by Agilent Technologies, a global leader in life sciences, diagnostics, and applied chemical markets, for the Indian market. These initiatives included establishment of an India Solutions Center in Manesar; and a Biopharma Experience Center in Hyderabad. 2025 also saw Nandakumar Kalathil stepping in as the new Country General Manager for Agilent India. With over 25 years of experience in the analytical industry, Nanda brings extensive expertise in leadership, team management, and customer relations. To find out more about the company's growth plans in 2026 in India, BioSpectrum interacted with Nandakumar Kalathil, Country General Manager for Agilent India in detail. Edited excerpts:

time to read

4 mins

December 2025

Listen

Translate

Share

-
+

Change font size

Holiday offer front
Holiday offer back